Crescent Biopharma (CBIO) FCF Margin (2013 - 2026)
Crescent Biopharma's FCF Margin was -874.30% in Q1 2026.
Powered by 
Analysis
Crescent Biopharma (CBIO) FCF Margin (2013 - 2026) Analysis & Trends
For FY2025, FCF Margin at Crescent Biopharma came in at -668.12%, up 2658.17 percentage points from FY2024.
- FCF Margin shows a five-year change of -281.32 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -3326.29% in FY2024 (+345686.68 pp), -349012.97% in FY2023 (-286957.40 pp), -62055.57% in FY2022 (-57097.29 pp) and -4958.28% in FY2021 (-4571.48 pp).
- The Q1 2026 figure marks the highest quarterly FCF Margin since Q1 2020.
- The best year-over-year quarter for FCF Margin over five years was Q2 2022 (a gain of 9567409.84 percentage points); the worst was Q1 2022 (a drop of 193012.27 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Crescent Biopharma | 418.60 Mn | -288.70 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -874.30% |
| Sep 30, 2024 | -4,334.38% |
| Jun 30, 2024 | -3,391.66% |
| Mar 31, 2024 | -2,779.43% |
| Dec 31, 2023 | -1,486.90% |
| Sep 30, 2023 | -1,422.48% |
| Jun 30, 2023 | -1,040.99% |
| Mar 31, 2023 | -1,995.82% |
| Jun 30, 2022 | -21,695.80% |
| Mar 31, 2022 | -194,350.88% |
| Dec 31, 2021 | -72,675.25% |
| Sep 30, 2021 | -19,582.49% |
| Jun 30, 2021 | -9,589,105.63% |
| Mar 31, 2021 | -1,338.62% |
| Dec 31, 2020 | -5,968.15% |
| Sep 30, 2020 | -1,151.97% |
| Mar 31, 2020 | -38.98% |
| Dec 31, 2019 | -2,103.37% |
| Dec 31, 2018 | -953.24% |
| Sep 30, 2016 | -41,607.50% |
API Access
Crescent Biopharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();